2012
DOI: 10.1146/annurev-publhealth-031811-124553
|View full text |Cite
|
Sign up to set email alerts
|

Economic Evaluation of Pharmaco- and Behavioral Therapies for Smoking Cessation: A Critical and Systematic Review of Empirical Research

Abstract: Economic evaluations are an important tool to improve our understanding of the costs and effects of health care services and to create sustainable health care systems. This article critically assesses empirical evidence from economic evaluations of pharmaco- and behavioral therapies for smoking cessation. A comprehensive literature review of PubMed and the British National Health Service Economic Evaluation Database was conducted. The search identified 15 articles on nicotine-based pharmacotherapies, 12 articl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
33
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(35 citation statements)
references
References 75 publications
0
33
0
2
Order By: Relevance
“…Direct comparison of our results with published findings is challenging given the variability in the metrics of abstinence reported in other trials, the length of follow-up, the economic evaluation methods used and the study setting 40 53. Previous studies have used varying metrics for reporting costs, with some using average cost per quitter, and others (including ours) including both average cost per quitter and incremental cost-effectiveness 54.…”
Section: Discussionmentioning
confidence: 85%
“…Direct comparison of our results with published findings is challenging given the variability in the metrics of abstinence reported in other trials, the length of follow-up, the economic evaluation methods used and the study setting 40 53. Previous studies have used varying metrics for reporting costs, with some using average cost per quitter, and others (including ours) including both average cost per quitter and incremental cost-effectiveness 54.…”
Section: Discussionmentioning
confidence: 85%
“…Although there is good evidence to show the cost effectiveness of TDT in HICs (Ruger & Lazar, 2012), not all interventions may be deemed cost effective when assessed against gross domestic product per capita in LMICs. This is illustrated in Vietnam, a lower MIC, where brief advice was "very cost effective," but pharmaceuticals at their current cost were not cost effective (Higashi & Barendregt, 2012).…”
Section: Refinement Of Tdtmentioning
confidence: 99%
“…1,3,4 Multiple tobacco cessation interventions have been shown to be cost effective, or even cost saving in some cases, across a broad range of populations. [5][6][7][8] These interventions include varenicline, sustained-release bupropion, nicotine replacement therapies (NRTs, such as gums and patches), and counseling interventions. While U.S. Public Health Service guidelines on tobacco use and dependence recommend that clinicians offer brief counseling interventions to all patients who use tobacco, rates of tobacco dependence detection and treatment in primary care have historically been suboptimal.…”
Section: Introductionmentioning
confidence: 99%